Could a cannabis drug calm Alzheimer's agitation?
NCT ID NCT04516057
Summary
This study is testing whether nabilone, a synthetic drug similar to cannabis, can safely and effectively treat agitation in people with Alzheimer's disease. Agitation is a common and distressing symptom that speeds up the need for nursing home care and increases caregiver stress. For 8 weeks, 112 participants will receive either nabilone or a placebo pill to see if it improves agitation and other symptoms like pain and poor nutrition.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AGITATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Centre for Addiction and Mental Health
RECRUITINGToronto, Ontario, Canada
Contact Email: •••••@•••••
-
London Health Sciences Centre
RECRUITINGLondon, Ontario, N6A 5W9, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Ontario Shores Centre for Mental Health Sciences
RECRUITINGWhitby, Ontario, L1N 5S9, Canada
Contact Email: •••••@•••••
-
St. Michael's Hospital
RECRUITINGToronto, Ontario, Canada
Contact Email: •••••@•••••
-
Sunnybrook Health Sciences Centre
RECRUITINGToronto, Ontario, M4N 3M5, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University of Calgary
RECRUITINGCalgary, Alberta, T2N 4N1, Canada
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.